Covid-19 related prescribing guidance
General Medicines-Related Issues
Teamnet COVID-19 Resources for Practices
Please click here for PSNC summary of updates and guidance relating to community pharmacy and COVID-19
Please click here for University of Liverpool COVID-19 drug interaction checker tool
Please click here for Primary Care advice for immunosuppression in Covid-19 patients
Yellow Card Reporting
The MHRA have launched a dedicated Yellow Card reporting site for healthcare products that are used in Coronavirus (COVID-19) treatment to be easily reported: coronavirus-yellowcard.mhra.gov.uk
Healthcare professionals, patients and carers are asked to report all suspected side effects to medicines or medical device adverse incidents related to COVID-19 treatment. This also includes medicines that patients and healthcare professionals are using off-label to treat COVID-19. Reporting will enable the MHRA to rapidly identify new and emerging side effects and medical device issues which may not have been previously known about, including diagnostic tests for COVID-19. This includes any medicines taken by patients to manage long-term, or pre-existing conditions that may influence the disease or have any potential interactions.
High Risk Drug Monitoring
The Covid-19 High Risk Drug Monitoring Guidance has now been withdrawn as it is now appropriate to return use of Shared Care Protocols for monitoring guidance. This decision is supported by UHBW, NBT and AWP.
Please click here for the good practice guide from the British Geriatrics Society (BGS) on Managing the COVID-19 pandemic in care homes.
Sick Day Rules
Please click here for BNSSG guidance on sick day rules (preventing dehydration during periods of acute illness)
Inflammatory Bowel Disease
Please click here for advice from International Organization for the study of Inflammatory Bowel Disease during the COVID-19 outbreak.
Please click here for patient advice from Crohn's and Colitis UK during the COVID-19 outbreak.
Please click here for advice from British Society of Gastroenterology on use of immunosuppression during the COVID-19 outbreak.
Please click here for NICE COVID-19 rapid guideline: gastrointestinal and liver conditions treated with drugs affecting the immune response.
Please click here for the NHSE advice regarding anticoagulation during the COVID-19 outbreak
Please see BNSSG COVID-19: Coagulopathy, Thrombosis prevention and DIC
Please click here for information, guidance and resources from the British Thoracic Society (BTS) to support the respiratory community during the COVID-19 pandemic
Central Nervous System
The Association of British Neurologists hosts guidance on COVID-19 for people with neurological conditions. Please click here for ABN Guidelines on Covid-19.
Please click here for CAS alert for the NHSE message regarding use of ibuprofen during the COVID-19 outbreak. (14/4/2020)
Please click here for NICE evidence summary on the use of ibuprofen during the COVID-19 outbreak (14/4/20)
Please click here to visit Avon and Wiltshire Mental Health Partnership (AWP) website for further information
The MHRA have provided temporary advice for the 'Valproate Pregnancy Prevention Programme' during the Coronavirus (COVID-19) pandemic - available here
Obstetrics and Gynaecology
Please click here for specific advice from Faculty of Sexual and Reproductive Health (FSRH) regarding provision of effective contraception during the COVID-19 outbreak.
Update, The Faculty of Sexual and Reproductive Healthcare (FSRH) makes recommendations relating to contraceptive services at times when lockdown restrictions are eased. It is anticipated that following the current period of Covid-19 lockdown, there will be an ongoing requirement for social distancing. Please click here for advice.
Malignant Disease and Immunosuppression
Please click here for COVID-19 guidance from British Society of Rheumatology
Please click here for guidance on management of patients on corticosteroids.
This guidance links to the Society of Endocrinology's advice on managing adrenal crisis during COVID-19
Please click here for patient advice from Kidney Care UK during the COVID-19 outbreak.
Systemic Anti-cancer treatments
Please click here for NICE rapid guideline on delivery of systemic anticancer treatments during COVID-19 outbreak.